Neurones (NRO) Q2 2024 TU earnings summary

Executive summary

• Achieved 9.1% revenue growth in H1 2024, with 8.2% organic growth, reflecting strong business momentum.

• Key advances in Data, Digital Projects, Secure Cloud, Cybersecurity, and SAP Services.

• Leveraging Data expertise to develop GenAI use cases for clients and internal solutions.

Financial highlights

• H1 2024 revenues reached €402.4m, up from €368.7m in H1 2023.

• Operating profit for H1 2024 was 9.2% of revenues, after 0.9% bonus share expenses.

Outlook and guidance

• Full-year 2024 revenue forecast maintained at around €800m.

• Operating profit expected to be around 9.5% for the full year, barring unforeseen political or economic events.